Asston Pharmaceuticals Ltd

BSE: 544445

₹82.53

up-down-arrow-0.25 (-0.30%)

As on 15-Jun-2026IST

Market cap

info icon

₹70 Cr

Revenue (TTM)

info icon

₹25 Cr

P/E Ratio

info icon

18.2

P/B Ratio

info icon

1.8

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score5/10

Growth Score fund-quick-summary-circle

Growth Score9/10

Valuation Score fund-quick-summary-circle

Valuation Score6/10

Momentum Score fund-quick-summary-circle

Momentum Score3/10

Asston Pharmaceuticals Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 82.05 High: 83.00

52 Week Range

Low: 61.02 High: 126.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹4 Cr

  • ROEROE information

    50.6 %

  • ROCEROCE information

    42.6 %

  • Industry P/EIndustry P/E information

    49.21

  • EV/EBITDAEV/EBITDA information

    13.9

  • Debt to EquityDebt to Equity information

    0.7

  • Book ValueBook Value information

    ₹17.1

  • EPSEPS information

    ₹6.9

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    8,512,360

Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Asston Pharmaceuticals
0.0 7.5 10.0 -- -- -- --
BSE Healthcare*
8.8 0.1 10.4 7.4 23.8 13.3 12.1
As on 15-Jun-2026  |  *As on 16-Jun-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Asston Pharmaceuticals
82.5 70.3 25.0 4.3 -- 50.6 18.2 1.8
1,051.2 12,906.7 2,551.8 564.5 28.3 18.4 22.9 3.9
504.3 8,749.6 947.3 247.8 28.5 18.9 35.3 6.4
1,380.2 14,448.0 1,054.9 256.3 27.8 13.7 55.4 7.2
1,705.6 32,327.5 9,203.5 941.3 15.4 19.6 35 6.5
17,056.0 21,873.6 2,023.0 364.0 23.9 20.8 60.1 11.7
960.9 4,872.1 811.3 21.0 0.7 2.1 237.1 3.8
1,283.2 5,904.3 649.5 121.6 23.7 13.2 51.2 6.3
822.6 9,295.7 502.0 138.7 -- 32.8 53.8 10.5
269.9 7,112.5 7.1 -276.3 -4,077.5 -63.3 -- 12.0

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Asston Pharmaceuticals

--

Edit peer-selector-edit
loading...
loading...

FAQs for Asston Pharmaceuticals

The share price of Asston Pharmaceuticals Ltd is ₹82.53 (BSE) as of 15-Jun-2026 IST. Asston Pharmaceuticals Ltd has given a return of --% in the last 1 years.

The P/E ratio of Asston Pharmaceuticals Ltd is 18.18 times as on 15-Jun-2026, a 63 discount to its peers’ median range of 49.21 times.
The P/B ratio of Asston Pharmaceuticals Ltd is 1.84 times as on 15-Jun-2026, a 64 discount to its peers’ median range of 5.10 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2025
0.00
0.00

The 52-week high and low of Asston Pharmaceuticals Ltd are Rs 126.00 and Rs 61.02 as of 16-Jun-2026.

Asston Pharmaceuticals Ltd has a market capitalisation of ₹ 70 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Asston Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.